SEC 13F Intelligence

Aristotle Atlantic Partners, LLC / TECH

Aristotle Atlantic Partners, LLC’s Bio-Techne Corp Position

Does Aristotle Atlantic Partners, LLC own Bio-Techne Corp (TECH)? Yes — 612.8K shares worth $32M (+1.50% of its 13F portfolio) as of Q1 2026, down from 636.8K shares the prior filed quarter.

Position Value
$32M
Q1 2026
Shares
612.8K
% of Portfolio
+1.50%
Quarters Held
30
currently held

Position History TECH

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $6MQ2 ’19: $7MQ3 ’19: $6MQ4 ’19: $19MQ4 ’19Q1 ’20: $14MQ2 ’20: $24MQ3 ’20: $23MQ4 ’20: $28MQ4 ’20Q1 ’21: $34MQ2 ’21: $41MQ3 ’21: $44MQ4 ’21: $49MQ4 ’21Q1 ’22: $42MQ2 ’22: $32MQ3 ’22: $37MQ4 ’22: $43MQ4 ’22Q1 ’23: $39MQ2 ’23: $54MQ3 ’23: $44MQ4 ’23: $59MQ4 ’23Q1 ’24: $52MQ2 ’24: $52MQ3 ’24: $63MQ4 ’24: $54MQ4 ’24Q1 ’25: $57MQ2 ’25: $54MQ3 ’25: $57MQ4 ’25: $37MQ4 ’25Q1 ’26: $32Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026612.8K$32M+1.50%
Q4 2025636.8K$37M+1.71%
Q3 20251.03M$57M+1.66%
Q2 20251.05M$54M+1.65%
Q1 2025966.4K$57M+1.91%
Q4 2024754.4K$54M+1.71%
Q3 2024785.5K$63M+1.95%
Q2 2024721.7K$52M+1.68%
Q1 2024735.8K$52M+1.69%
Q4 2023759.4K$59M+2.06%
Q3 2023653.6K$44M+1.78%
Q2 2023662.2K$54M+2.04%
Q1 2023523.2K$39M+2.00%
Q4 2022523.2K$43M+2.43%
Q3 2022129.1K$37M+2.23%
Q2 202293.3K$32M+2.49%
Q1 202297.0K$42M+2.60%
Q4 202195.6K$49M+2.87%
Q3 202191.2K$44M+2.92%
Q2 202190.1K$41M+2.68%
Q1 202189.0K$34M+2.49%
Q4 202087.0K$28M+2.13%
Q3 202091.7K$23M+2.00%
Q2 202090.6K$24M+2.30%
Q1 202075.0K$14M+2.17%
Q4 201985.5K$19M+2.40%
Q3 201933.0K$6M+1.86%
Q2 201931.9K$7M+1.94%
Q1 201930.5K$6M+1.84%
Q4 201829.2K$4M+1.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aristotle Atlantic Partners, LLC’s full portfolio or all institutional holders of TECH.